HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - NYSE:HIMS - US4330001060 - Common Stock
52.9 USD
+2.55 (+5.06%)
Overall HIMS gets a fundamental rating of 6 out of 10. We evaluated HIMS against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HIMS get a neutral evaluation. Nothing too spectacular is happening here. HIMS is valued quite expensive, but it does show an excellent growth. These ratings could make HIMS a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
HIMS had a positive operating cash flow in the past year.
In the past 5 years HIMS reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
HIMS's Return On Assets of 10.31% is amongst the best of the industry. HIMS outperforms 95.05% of its industry peers.
Looking at the Return On Equity, with a value of 34.41%, HIMS belongs to the top of the industry, outperforming 96.04% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.74%, HIMS is doing good in the industry, outperforming 68.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROIC | 6.74% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS's Profit Margin of 9.62% is amongst the best of the industry. HIMS outperforms 93.07% of its industry peers.
Looking at the Operating Margin, with a value of 6.80%, HIMS is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
The Gross Margin of HIMS (76.20%) is better than 89.11% of its industry peers.
In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HIMS has more shares outstanding
Compared to 5 years ago, HIMS has more shares outstanding
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 7.09 indicates that HIMS is not in any danger for bankruptcy at the moment.
HIMS has a Altman-Z score of 7.09. This is amongst the best in the industry. HIMS outperforms 89.11% of its industry peers.
HIMS has a debt to FCF ratio of 8.11. This is a slightly negative value and a sign of low solvency as HIMS would need 8.11 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.11, HIMS is in line with its industry, outperforming 57.43% of the companies in the same industry.
HIMS has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
HIMS has a worse Debt to Equity ratio (1.72) than 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Altman-Z | 7.09 |
ROIC/WACC0.78
WACC8.68%
2.3 Liquidity
A Current Ratio of 4.98 indicates that HIMS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.98, HIMS belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
HIMS has a Quick Ratio of 4.46. This indicates that HIMS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.46, HIMS belongs to the best of the industry, outperforming 92.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 900.00%, which is quite impressive.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.35% on average per year.
The Revenue has grown by 88.69% in the past year. This is a very strong growth!
HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
3.2 Future
Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 41.75% on average per year.
HIMS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.95% yearly.
EPS Next Y11.07%
EPS Next 2Y23.28%
EPS Next 3Y24.28%
EPS Next 5Y41.75%
Revenue Next Year59.8%
Revenue Next 2Y38.24%
Revenue Next 3Y31.33%
Revenue Next 5Y20.95%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
HIMS is valuated quite expensively with a Price/Earnings ratio of 66.13.
HIMS's Price/Earnings is on the same level as the industry average.
HIMS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.20.
The Price/Forward Earnings ratio is 64.46, which means the current valuation is very expensive for HIMS.
HIMS's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of HIMS to the average of the S&P500 Index (22.70), we can say HIMS is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.13 | ||
| Fwd PE | 64.46 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 100.05 | ||
| EV/EBITDA | 67.36 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HIMS may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 24.28% in the coming years.
PEG (NY)5.98
PEG (5Y)1.1
EPS Next 2Y23.28%
EPS Next 3Y24.28%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:HIMS (9/18/2025, 10:25:09 AM)
52.9
+2.55 (+5.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners81.86%
Inst Owner Change9.04%
Ins Owners10.73%
Ins Owner Change-0.54%
Market Cap11.96B
Analysts70
Price Target51.38 (-2.87%)
Short Float %38.53%
Short Ratio2.46
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.23%
Min EPS beat(2)10.29%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)185.99%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)152.2%
EPS beat(12)11
Avg EPS beat(12)111.23%
EPS beat(16)12
Avg EPS beat(16)74.99%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)6.75%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.23%
Revenue beat(12)9
Avg Revenue beat(12)2.03%
Revenue beat(16)13
Avg Revenue beat(16)3.23%
PT rev (1m)0%
PT rev (3m)7.12%
EPS NQ rev (1m)-11.37%
EPS NQ rev (3m)-32.59%
EPS NY rev (1m)-11.98%
EPS NY rev (3m)-5.16%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)-1.31%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.13 | ||
| Fwd PE | 64.46 | ||
| P/S | 5.94 | ||
| P/FCF | 100.05 | ||
| P/OCF | 45.7 | ||
| P/B | 21.25 | ||
| P/tB | 29.57 | ||
| EV/EBITDA | 67.36 |
EPS(TTM)0.8
EY1.51%
EPS(NY)0.82
Fwd EY1.55%
FCF(TTM)0.53
FCFY1%
OCF(TTM)1.16
OCFY2.19%
SpS8.91
BVpS2.49
TBVpS1.79
PEG (NY)5.98
PEG (5Y)1.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 23.47% | ||
| ROICexgc | 35.76% | ||
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% | ||
| FCFM | 5.94% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Debt/EBITDA | 5.84 | ||
| Cap/Depr | 486.96% | ||
| Cap/Sales | 7.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 157.56% | ||
| Profit Quality | 61.73% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 | ||
| Altman-Z | 7.09 |
F-Score6
WACC8.68%
ROIC/WACC0.78
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
EPS Next Y11.07%
EPS Next 2Y23.28%
EPS Next 3Y24.28%
EPS Next 5Y41.75%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
Revenue Next Year59.8%
Revenue Next 2Y38.24%
Revenue Next 3Y31.33%
Revenue Next 5Y20.95%
EBIT growth 1Y821.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year364.13%
EBIT Next 3Y97.59%
EBIT Next 5Y58.64%
FCF growth 1Y927.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y922.97%
OCF growth 3YN/A
OCF growth 5YN/A